Skip to main content
. 2024 Oct 9;16(10):e71170. doi: 10.7759/cureus.71170

Table 2. History of COVID-19 infection and vaccination data among vaccinated population.

SD: standard deviation 

COVID-19 infection and vaccination data Frequency %
Previously had a positive test for COVID-19    
Yes 816 60.9
No 524 39.1
Type of vaccine    
Pfizer/BioNTech       909 67.84
Oxford/AstraZeneca           261 19.48
Sinopharm          170 12.69
Number of doses of COVID-19 vaccine received    
One dose 181 13.51
Two doses 1030 76.87
Three doses 129 9.63
Infected with COVID-19 after vaccination    
Yes 434 32.39
No 906 67.61
Infected with COVID-19 after which dose     
1st dose 142 32.72
2nd dose 255 58.76
3rd dose 37 8.52
Post-vaccination side effects    
Yes 1031 76.94
No 309 23.06
Duration of symptoms after vaccination (Day Mean±SD) 2.8±1.92  
Severity of side effects after vaccination     
Mild 493 36.79
Moderate 389 29.03
Severe 149 11.12
No symptoms 309 23.06